Literature DB >> 14587078

Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells.

Steffi Kopprasch1, Jens Pietzsch, Juergen Graessler.   

Abstract

Chemiluminescence is a widely used tool to detect extracellular generation of reactive oxygen species (ROS). In the present study we tested four different chemilumigenic substrates (CLS)--luminol, isoluminol, lucigenin and pholasin-to detect extracellular CL in different cell types: polymorphonuclear leukocytes (PMN); DMSO-differentiated HL-60 cells; murine macrophages (RAW 264.7); and TNF alpha-stimulated human endothelial cells (HUVEC). Extracellular ROS production was calculated by subtracting intracellular CL response in the presence of superoxide dismutase and catalase from the overall CL response in the absence of enzymes. CL varied considerably in dependence on the CLS and the stimulus used to evoke ROS generation. Luminol (oxidized LDL and zymosan stimulation) and isoluminol (FMLP and PMA stimulation) were the most effective CLS for PMN. Using 5 micromol/L lucigenin as CLS, small but consistent CL responses could be obtained in macrophages stimulated with PMA, zymosan or oxidized LDL. FMLP-stimulated extracellular CL in H-60 cells, HUVEC and macrophages was detected with the greatest sensitivity by pholasin. Our results demonstrate that none of the investigated CLS consistently yielded the highest CL quantum, either in different cell types with one stimulating agent or by different stimulating agents in one cell type. To get the highest CL quantum in experimental studies, we recommend optimizing the CLS depending on the cell type and the ROS-generating stimulus used. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587078     DOI: 10.1002/bio.737

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  7 in total

1.  Nicotine, smoking, podocytes, and diabetic nephropathy.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Mohammed Siddiqui; Gabriel Rezonzew; Runxia Tian; Surya V Seshan; Alecia N Muwonge; Nicholas J Wong; Evren U Azeloglu; Alessia Fornoni; Sandra Merscher; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-18

2.  Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.

Authors:  Daryl M Okamura; Nadia M Bahrami; Shuyu Ren; Katie Pasichnyk; Juliana M Williams; Jon A Gangoiti; Jesus M Lopez-Guisa; Ikuyo Yamaguchi; Bruce A Barshop; Jeremy S Duffield; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

3.  Irradiation at 634 nm releases nitric oxide from human monocytes.

Authors:  Ann Lindgård; Lillemor Mattsson Hultén; Lennart Svensson; Bassam Soussi
Journal:  Lasers Med Sci       Date:  2006-11-21       Impact factor: 3.161

4.  Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells.

Authors:  Dongli Yang; Susan G Elner; Zong-Mei Bian; Gerd O Till; Howard R Petty; Victor M Elner
Journal:  Exp Eye Res       Date:  2007-06-27       Impact factor: 3.467

Review 5.  Reactive oxygen species in spermatozoa: methods for monitoring and significance for the origins of genetic disease and infertility.

Authors:  Mark A Baker; R John Aitken
Journal:  Reprod Biol Endocrinol       Date:  2005-11-29       Impact factor: 5.211

Review 6.  Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.

Authors:  Shelby Loraine Hatton; Manoj Kumar Pandey
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

7.  Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study.

Authors:  Barbara Kofler; Edith E Mueller; Waltraud Eder; Olaf Stanger; Richard Maier; Martin Weger; Anton Haas; Robert Winker; Otto Schmut; Bernhard Paulweber; Bernhard Iglseder; Wilfried Renner; Martina Wiesbauer; Irene Aigner; Danijela Santic; Franz A Zimmermann; Johannes A Mayr; Wolfgang Sperl
Journal:  BMC Med Genet       Date:  2009-04-21       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.